LB PHARMACEUTICALS INC (LBRX)
Nasdaq · Pharmaceutical Preparations · Inc. DE
What they're doing
Between 2026-06-21 and 2026-09-19, public records show 3 signals for LB PHARMACEUTICALS INC. Most notable: 2026-09-03: Filed 8-K disclosing director or officer change; 2026-09-15: Filed 8-K disclosing director or officer change; 2026-07-29: Filed 8-K disclosing material agreement. Federal contract obligations over the last 24 months total $0. This summary was assembled automatically from SEC EDGAR, USAspending.gov, U.S. Senate lobbying disclosures and Wikimedia pageview counts.
Generated 2026-09-19 from public records.
Signals, last 12 months
- Material 8-K filingFiled 8-K disclosing director or officer change
- Material 8-K filingFiled 8-K disclosing director or officer change
- Material 8-K filingFiled 8-K disclosing material agreement
- Material 8-K filingFiled 8-K disclosing director or officer change
- Material 8-K filingFiled 8-K disclosing director or officer change
- Material 8-K filingFiled 8-K disclosing director or officer change
- Material 8-K filingFiled 8-K disclosing material agreement
- Material 8-K filingFiled 8-K disclosing material agreement
Insider transactions
| Date | Insider | Role | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2025-09-12 | Deep Track Capital, LP | ten percent owner | C | 686,138 | — | — |
| 2025-09-12 | Deep Track Capital, LP | ten percent owner | P | 2,000,000 | 15 | $30,000,000 |
| 2025-09-12 | Deep Track Capital, LP | ten percent owner | P | 666,666 | 15 | $9,999,990 |
| 2025-09-12 | Pontifax Management 4 G.P. (2015) Ltd. | ten percent owner | C | 411,681 | — | — |
| 2025-09-12 | Pontifax Management 4 G.P. (2015) Ltd. | ten percent owner | P | 1,000,000 | 15 | $15,000,000 |
| 2025-09-12 | Nussbaum Ran | director | C | 411,681 | — | — |
| 2025-09-12 | Nussbaum Ran | director | P | 1,000,000 | 15 | $15,000,000 |
| 2025-09-12 | Vida Ventures GP III, L.L.C. | ten percent owner | P | 332,566 | 15 | $4,988,490 |
| 2025-09-12 | Vida Ventures GP III, L.L.C. | ten percent owner | P | 767 | 15 | $11,505 |
| 2025-09-12 | Vida Ventures GP III, L.L.C. | ten percent owner | C | 547,648 | — | — |
| 2025-09-12 | Vida Ventures GP III, L.L.C. | ten percent owner | C | 1,262 | — | — |
| 2025-09-12 | Deep Track Biotechnology Master Fund, Ltd.; Deep Track Capital, LP; KROIN DAVID | ten percent owner | C | 686,138 | — | — |
| 2025-09-12 | Deep Track Biotechnology Master Fund, Ltd.; Deep Track Capital, LP; KROIN DAVID | ten percent owner | P | 2,000,000 | 15 | $30,000,000 |
| 2025-09-12 | Deep Track Biotechnology Master Fund, Ltd.; Deep Track Capital, LP; KROIN DAVID | ten percent owner | P | 666,666 | 15 | $9,999,990 |
| 2025-09-12 | Pontifax Management 4 G.P. (2015) Ltd. | ten percent owner | C | 411,681 | — | — |
| 2025-09-12 | Pontifax Management 4 G.P. (2015) Ltd. | ten percent owner | P | 1,000,000 | 15 | $15,000,000 |
| 2025-09-12 | Nussbaum Ran | director | C | 411,681 | — | — |
| 2025-09-12 | Nussbaum Ran | director | P | 1,000,000 | 15 | $15,000,000 |
| 2025-09-12 | Vida Ventures GP III, L.L.C.; Vida Ventures III, L.P.; Vida Ventures III-A, L.P.; Belldegrun Arie; Vida Ventures Management Co. LLC | ten percent owner | C | 547,648 | — | — |
| 2025-09-12 | Vida Ventures GP III, L.L.C.; Vida Ventures III, L.P.; Vida Ventures III-A, L.P.; Belldegrun Arie; Vida Ventures Management Co. LLC | ten percent owner | C | 1,262 | — | — |
| 2025-09-12 | Vida Ventures GP III, L.L.C.; Vida Ventures III, L.P.; Vida Ventures III-A, L.P.; Belldegrun Arie; Vida Ventures Management Co. LLC | ten percent owner | P | 332,566 | 15 | $4,988,490 |
| 2025-09-12 | Vida Ventures GP III, L.L.C.; Vida Ventures III, L.P.; Vida Ventures III-A, L.P.; Belldegrun Arie; Vida Ventures Management Co. LLC | ten percent owner | P | 767 | 15 | $11,505 |
Federal contracts
No federal contract actions on record for this recipient mapping.
Lobbying
No federal lobbying filings on record for this client mapping.
Public attention
No Wikipedia pageview data linked to this company.
Recent filings
- 2026-09-15 8-K
- 2026-09-15 424B3
- 2026-09-14 3
- 2026-09-03 424B3
- 2026-09-03 8-K
- 2026-08-14 SCHEDULE 13G/A
- 2026-08-11 424B3
- 2026-08-11 10-Q
- 2026-08-11 8-K
- 2026-08-03 4
- 2026-07-29 424B3
- 2026-07-29 8-K
- 2026-07-22 424B3
- 2026-07-22 8-K
- 2026-07-16 SCHEDULE 13G
- 2026-06-10 424B3
- 2026-06-10 8-K
- 2026-06-09 144
- 2026-06-09 424B3
- 2026-06-09 8-K